|
List of Contributors Preface Chapter 1 Downstream processing of monoclonal antibodies: current practices and future opportunities (Brian Kelley) Chapter 2 The development of antibody purification technologies (John Curling) Chapter 3 Harvest and recovery of monoclonal antibodies: cell removal and clarification (Abhinav A. Shukla and Dustin Costello) Chapter 4 Next‐generation clarification technologies for the downstream processing of antibodies (Nripen Singh and Srinivas Chollangi) Chapter 5 Protein A-based affinity chromatography (Hans J Johansson) Chapter 6 Purification of human monoclonal antibodies: non‐protein a strategies (Alahari Arunakumari and Jue Wang) Chapter 7 Hydrophobic interaction chromatography for the purification of antibodies (Judith Thoma and Egbert Müller) Chapter 8 Disposable prepacked‐bed chromatography for downstream purification: form, fit, function, and industry adoption (Stephen K. Tingley) Chapter 9 Integrated polishing steps for monoclonal antibody purification (Sanchayita Ghose, Mi Jin, Jia Liu, John Hickey and Steven Lee) Chapter 10 Orthogonal virus clearance: applications in monoclonal antibody production (Joe X. Zhou) Chapter 11 Development of a platform process for the purification of therapeutic monoclonal antibodies (Yuling Li, Min Zhu, Haibin Luo and Justin R. Weaver) Chapter 12 The evolution of platform technologies for the downstream processing of antibodies (Lee Allen) Chapter 13 Countercurrent chromatography for the purification of monoclonal antibodies, bispecifics and antibody–drug conjugates (Thomas Müller-Späth and Massimo Morbidelli) Chapter 14 The evolution of continuous chromatography from bulk chemicals to biopharma (Marc Bisschops) Chapter 15 Process economic drivers in industrial monoclonal antibody manufacture (Suzanne S. Farid) Chapter 16 Design and optimization of manufacturing (Andrew Sinclair) Chapter 17 Smart design for an efficient facility with a validated disposable system (Joe X. Zhou) Chapter 18 High‐throughput screening and modeling technologies for process development in antibody purification (Tobias Hahn, Thiemo Huuk and Jürgen Hubbuch) Chapter 19 Downstream processing of Fc fusion proteins, bispecific antibodies and antibody–drug conjugates (Abhinav A Shukla and Carly Catella) Chapter 20 Manufacturing concepts for antibody–drug conjugates (Thomas Rohrer) Chapter 21 Purification of IgM and IgA (Charlotte Cabanne and Xavier Santarelli) Chapter 22 Very-large-scale production of monoclonal antibodies in plants (Johannes F. Buyel and Richard M. Twyman) Chapter 23 Trends in formulation and drug delivery for antibodies (Hanns-Christian Mahler and Andrea Allmendinger) Chapter 24 Future of antibody purification (Anurag Rathore, David Roush and Nihal Tugcu) Chapter 25 Current CMC considerations for mAb and bsAb purification process development and manufacturing (Yanhuai (Richard) Ding, Bruce Andrien and Mark Aimone) Chapter 26 Convective chromatography media for advanced antibody processing (James Stout, Mochao Zhao, Takuo Kawase and Raja Ghosh) Chapter 27 Relevance and biophysical attributes of monoclonal antibody isoforms (Solomon Isu and Melissa Holstein) Index |
UWE GOTTSCHALK, PhD, is an Operating Partner at Keensight Capital, a European growth buyout investor specializing in technology and healthcare. Over more than thirty years in biopharmaceutical manufacturing, he held senior positions at Lonza, Sartorius, and Bayer, building extensive expertise in downstream processing technologies and large-scale purification operations. His career spans the full spectrum of antibody production challenges, from process development through commercial manufacturing.